• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ⅢB型黏多糖贮积症的神经行为表型:一项探索性研究。

The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.

作者信息

Shapiro E, King K, Ahmed A, Rudser K, Rumsey R, Yund B, Delaney K, Nestrasil I, Whitley C, Potegal M

机构信息

University of Minnesota Department of Pediatrics.

University of Minnesota Division of Biostatistics.

出版信息

Mol Genet Metab Rep. 2016 Mar 1;6:41-47. doi: 10.1016/j.ymgmr.2016.01.003.

DOI:10.1016/j.ymgmr.2016.01.003
PMID:26918231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4762067/
Abstract

OBJECTIVES

Our goal was to describe the neurobehavioral phenotype in mucopolysaccharidosis Type IIIB (MPS IIIB). Parents report that behavioral abnormalities are a major problem in MPS III posing serious challenges to parenting and quality-of-life for both patient and parent. Our previous research on MPS IIIA identified autistic symptoms, and a Klüver-Bucy-type syndrome as indicated by reduced startle and loss of fear associated with amygdala atrophy. We hypothesized that MPS IIIB would manifest similar attributes when assessed with the same neurobehavioral protocol.

METHODS

Ten patients with MPS IIIB were compared with 9 MPS IIIA patients, all older than 6. 8 younger children with Hurler syndrome (1H) were chosen as a comparison group for the Risk Room procedure; MPS IH does not directly affect social/emotional function and these younger children were closer to the developmental level of the MPS IIIB group. To examine disease severity, cognitive ability was assessed. Four evaluations were used: the Risk Room procedure (to measure social-emotional characteristics, especially fear and startle responses), the Autism Diagnostic Observation Schedule (ADOS), the Sanfilippo Behavior Rating Scale (SBRS), and amygdala brain volumes calculated from manually-traced MRI images.

RESULTS

The two groups are equivalent in severity and show severe cognitive impairment. On the ADOS, the MPS IIIB patients exhibited the same autistic features as IIIA. The IIIB means differed from MPS IH means on most measures. However, the IIIB group did not approach the Risk Room stranger, like the MPS IH group who kept their distance, but unlike the IIIA group who showed no fear of the stranger. On the SBRS, the MPS IIIB patients were described as more inattentive and more fearful, especially of new people than the MPS IIIA. Onsets of some disease characteristics appeared more closely spaced and slightly earlier in MPS IIIB than IIIA.

CONCLUSIONS

On most behavioral measures, MPS IIIB patients did not differ substantially from MPS IIIA patients over age six, demonstrating autistic features and a Klüver Bucy-like syndrome including lack of fear and poor attention. Delay in onset of behavioral symptoms was associated with later diagnosis in two patients. Lack of fear, poor attention, and autistic-like symptomatology are as characteristic of MPS IIIB as they are of MPS IIIA. A possible difference is that the some behavioral abnormalities develop more quickly in MPS IIIB, If this is so, these patients may become at risk for harm and present a challenge for parenting even earlier than do those with MPS IIIA. .In future clinical trials of new treatments, especially with respect to quality of life and patient management, improvement of these behaviors will be an essential goal. Because very young patients were not studied, prospective natural history documentation of the early development of abnormal behaviors in MPS IIIB is needed.

摘要

目的

我们的目标是描述ⅢB型黏多糖贮积症(MPS IIIB)的神经行为表型。家长们报告称,行为异常是MPS III中的一个主要问题,给患者及其家长的养育和生活质量带来了严峻挑战。我们之前对ⅢA型MPS的研究发现了自闭症症状,以及一种类似Klüver-Bucy综合征的症状,表现为惊吓反应减弱和与杏仁核萎缩相关的恐惧缺失。我们假设,当采用相同的神经行为方案进行评估时,ⅢB型MPS会表现出类似的特征。

方法

将10例ⅢB型MPS患者与9例ⅢA型MPS患者进行比较,所有患者年龄均超过6岁。选择8例年龄较小的Hurler综合征(1H)患儿作为“风险室”程序的对照组;1H型MPS不会直接影响社会/情感功能,且这些年龄较小的儿童更接近ⅢB型MPS组的发育水平。为了评估疾病严重程度,对认知能力进行了评估。采用了四项评估:“风险室”程序(用于测量社会情感特征,尤其是恐惧和惊吓反应)、自闭症诊断观察量表(ADOS)、Sanfilippo行为评定量表(SBRS),以及通过手动追踪MRI图像计算的杏仁核脑容量。

结果

两组在严重程度上相当,均表现出严重的认知障碍。在ADOS上,ⅢB型MPS患者表现出与ⅢA型相同的自闭症特征。在大多数测量指标上,ⅢB型患者的均值与1H型MPS患者的均值不同。然而,ⅢB型组不像1H型MPS组那样与“风险室”中的陌生人保持距离,也不像ⅢA型组那样对陌生人毫无恐惧。在SBRS上,与ⅢA型MPS患者相比,ⅢB型MPS患者被描述为更注意力不集中、更恐惧,尤其是对陌生人。ⅢB型MPS的一些疾病特征的发病间隔似乎更短,且比ⅢA型稍早出现。

结论

在大多数行为测量指标上,6岁以上的ⅢB型MPS患者与ⅢA型MPS患者没有显著差异,表现出自闭症特征和类似Klüver-Bucy综合征的症状,包括缺乏恐惧和注意力不集中。两名患者的行为症状出现延迟与诊断较晚有关。缺乏恐惧、注意力不集中和类似自闭症的症状是ⅢB型MPS和ⅢA型MPS的共同特征。一个可能的差异是,ⅢB型MPS的一些行为异常发展得更快。如果是这样,这些患者可能比ⅢA型MPS患者更早面临伤害风险,给养育带来挑战。在未来新治疗方法的临床试验中,尤其是在生活质量和患者管理方面,改善这些行为将是一个重要目标。由于未对非常年幼的患者进行研究,因此需要对ⅢB型MPS异常行为的早期发展进行前瞻性自然病史记录。

相似文献

1
The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.ⅢB型黏多糖贮积症的神经行为表型:一项探索性研究。
Mol Genet Metab Rep. 2016 Mar 1;6:41-47. doi: 10.1016/j.ymgmr.2016.01.003.
2
Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndrome.黏多糖贮积症 IIIA 表现为克莱弗-比尔综合征的变异型。
J Clin Exp Neuropsychol. 2013;35(6):608-16. doi: 10.1080/13803395.2013.804035. Epub 2013 Jun 8.
3
Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.ⅢA型黏多糖贮积症的造血干细胞移植:病例描述及与基因型匹配对照组的比较
Mol Genet Metab Rep. 2020 Mar 23;23:100578. doi: 10.1016/j.ymgmr.2020.100578. eCollection 2020 Jun.
4
Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.对患有桑菲利波综合征儿童的行为进行量化:桑菲利波行为评定量表。
Mol Genet Metab. 2015 Apr;114(4):594-8. doi: 10.1016/j.ymgme.2015.02.008. Epub 2015 Mar 5.
5
Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.黏多糖贮积症 IIIA 型和 IIIB 型患儿一年内的纵向 MRI 脑容量变化。
Mol Genet Metab. 2021 Jun;133(2):193-200. doi: 10.1016/j.ymgme.2021.04.006. Epub 2021 Apr 27.
6
Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.黏多糖贮积症 IIIB 型小鼠模型中疾病早期标志物的特征。
J Neurodev Disord. 2024 Apr 17;16(1):16. doi: 10.1186/s11689-024-09534-z.
7
The natural history of neurocognition in MPS disorders: A review.MPS 疾病的神经认知自然史:综述。
Mol Genet Metab. 2021 May;133(1):8-34. doi: 10.1016/j.ymgme.2021.03.002. Epub 2021 Mar 11.
8
A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.III型黏多糖贮积症A和B型的前瞻性一年自然史研究:对临床试验设计的启示
Mol Genet Metab. 2016 Nov;119(3):239-248. doi: 10.1016/j.ymgme.2016.08.002. Epub 2016 Aug 18.
9
Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA.黏多糖贮积症 IIIA 型患儿获得性自闭症行为。
J Pediatr. 2014 May;164(5):1147-1151.e1. doi: 10.1016/j.jpeds.2014.01.007. Epub 2014 Feb 25.
10
An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.黏多糖贮积症 IIIA 型患者的观察性、前瞻性、多中心、自然史研究。
Mol Genet Metab. 2022 Feb;135(2):133-142. doi: 10.1016/j.ymgme.2021.12.002. Epub 2021 Dec 10.

引用本文的文献

1
Exploring Molecular and Phenotypic Characteristics of Arg234Gly and Asp312Asn Variants.探索Arg234Gly和Asp312Asn变体的分子和表型特征。
Mol Syndromol. 2025 Aug;16(4):342-353. doi: 10.1159/000542367. Epub 2024 Nov 6.
2
D1 dopamine receptor antagonists as a new therapeutic strategy to treat autistic-like behaviours in lysosomal storage disorders.D1多巴胺受体拮抗剂作为治疗溶酶体贮积症中自闭症样行为的一种新治疗策略。
Mol Psychiatry. 2025 Jan 26. doi: 10.1038/s41380-025-02904-6.
3
Anakinra in Sanfilippo syndrome: a phase 1/2 trial.

本文引用的文献

1
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.III型黏多糖贮积症A亚型的前瞻性自然史研究。
J Pediatr. 2016 Mar;170:278-87.e1-4. doi: 10.1016/j.jpeds.2015.11.079. Epub 2016 Jan 16.
2
Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.对患有桑菲利波综合征儿童的行为进行量化:桑菲利波行为评定量表。
Mol Genet Metab. 2015 Apr;114(4):594-8. doi: 10.1016/j.ymgme.2015.02.008. Epub 2015 Mar 5.
3
Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA.
安那白滞素治疗黏多糖贮积症 Sanfilippo 型:1/2 期临床试验。
Nat Med. 2024 Sep;30(9):2473-2479. doi: 10.1038/s41591-024-03079-3. Epub 2024 Jun 21.
4
Clinical and Molecular Characterization of Mucopolysaccharidosis Type 3A and 3B in a Turkish Series.土耳其一组黏多糖贮积症3A型和3B型的临床与分子特征
Mol Syndromol. 2024 Jun;15(3):194-201. doi: 10.1159/000535888. Epub 2024 Jan 16.
5
The significance of triple-capsid-mutant AAV8 for treatment of Sanfilippo Syndrome Type B.三衣壳突变体AAV8对治疗B型Sanfilippo综合征的意义。
Arch Stem Cell Ther. 2022;3(1):11-17. doi: 10.46439/stemcell.3.013.
6
The 100 Most Cited Kluver-Bucy Research Articles: A Bibliometric Analysis.被引用次数最多的100篇克吕弗-布西研究文章:一项文献计量分析。
Cureus. 2023 Sep 16;15(9):e45382. doi: 10.7759/cureus.45382. eCollection 2023 Sep.
7
Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys.经脑室内输注给予幼年食蟹猴曲拉西酶α的安全性、药代动力学及中枢神经系统分布
Toxicol Rep. 2023 Mar 1;10:357-366. doi: 10.1016/j.toxrep.2023.02.014. eCollection 2023.
8
Sanfilippo syndrome: consensus guidelines for clinical care.黏多糖贮积症 Sanfilippo 综合征:临床护理共识指南。
Orphanet J Rare Dis. 2022 Oct 27;17(1):391. doi: 10.1186/s13023-022-02484-6.
9
Delivering gene therapy for mucopolysaccharide diseases.为黏多糖病提供基因治疗。
Front Mol Biosci. 2022 Sep 12;9:965089. doi: 10.3389/fmolb.2022.965089. eCollection 2022.
10
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.Tralesinidase Alfa 酶替代疗法可预防犬黏多糖贮积症 IIIB 型疾病表现。
J Pharmacol Exp Ther. 2022 Sep;382(3):277-286. doi: 10.1124/jpet.122.001119. Epub 2022 Jun 18.
黏多糖贮积症 IIIA 型患儿获得性自闭症行为。
J Pediatr. 2014 May;164(5):1147-1151.e1. doi: 10.1016/j.jpeds.2014.01.007. Epub 2014 Feb 25.
4
Age at disease onset: a key factor for understanding psoriatic disease.发病年龄:理解银屑病的关键因素。
Rheumatology (Oxford). 2014 Jul;53(7):1178-85. doi: 10.1093/rheumatology/ket363. Epub 2013 Nov 22.
5
Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome.神经退行性疾病患儿的神经发育评估方法:桑菲利波综合征
JIMD Rep. 2014;13:129-37. doi: 10.1007/8904_2013_269. Epub 2013 Nov 5.
6
Mucopolysaccharidosis Type IIIA presents as a variant of Klüver-Bucy syndrome.黏多糖贮积症 IIIA 表现为克莱弗-比尔综合征的变异型。
J Clin Exp Neuropsychol. 2013;35(6):608-16. doi: 10.1080/13803395.2013.804035. Epub 2013 Jun 8.
7
Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.黏多糖贮积症 III 型(Sanfilippo 综合征)和特发性发育迟缓、注意缺陷多动障碍或自闭症谱系障碍的误诊。
Acta Paediatr. 2013 May;102(5):462-70. doi: 10.1111/apa.12169. Epub 2013 Feb 6.
8
Age at disease onset predicts likelihood and rapidity of growth failure among infants and young children with spinal muscular atrophy types 1 and 2.1型和2型脊髓性肌萎缩症婴幼儿发病年龄可预测生长发育迟缓的可能性和速度。
J Child Neurol. 2012 Jul;27(7):845-51. doi: 10.1177/0883073811415680. Epub 2012 Mar 30.
9
Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece.法国、英国和希腊黏多糖贮积症 III 型的发病率和自然史。
Am J Med Genet A. 2011 Jan;155A(1):58-68. doi: 10.1002/ajmg.a.33779.
10
Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.黏多糖贮积症 IIIB 型可能主要表现为临床表型较轻。
J Inherit Metab Dis. 2010 Dec;33(6):759-67. doi: 10.1007/s10545-010-9199-y. Epub 2010 Sep 18.